Troubled Zymergen renegotiates loan, cuts 100 more jobs and loses co-founder

Synthetic biology company Zymergen Inc., which in August replaced CEO Josh Hoffman as its eco-friendly thin film for smartphone screens faltered, said it has renegotiated a loan that includes an earlier maturity date as it begins to cut 100 more jobs. The Emeryville company (NASDAQ: ZY) also said co-founder and operations chief Jed Dean will step down Oct. 31. Dean founded the company with Hoffman and Zach Serber in May 2013 to train microbes to spit out proteins, nucleic acids and the like that…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news